series-b
Stage
2015
Founded
3
Investors
About
Xilis develops a patient-derived microtumor platform to predict drug response and guide personalized cancer treatment in oncology.
Explore Xilis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.